Health Care [ 3/12 ] | Health Care Equipment & Supplies [ 33/74 ]
NYSE | Common Stock
Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally.
The company offers forefoot systems, including gorilla precision MTP plating system, gorilla precision lapidus plating system, phantom lapidus intramedullary nail system, Bun-Yo-Matic lapidus clamp, and precision MIS screw system; and fracture fixation systems comprising gorilla ankle fracture plating system, baby gorilla plating system, monster screw system, monkey bars external fixation system, R3Flex syndesmotic repair system, and phantom fibula nail system.
It also provides flatfoot systems, such as gorilla universal plating system, JAWS great white staple system, monster screw system, grappler suture anchor system, and mister tendon harvester system; ankle replacement system consists of metallic and plastic implant components, as well as ankle fusion plating system and phantom hindfoot nailing system; Charcot systems, including the joust beaming system, gorilla medial column plating system, and monkey rings external fixation system; and orthobiologics products, such as V92 cellular bone matrix, PRESERVE bone wedges, MgNum bone void filler, and BEAST demineralized bone matrix.
The company serves hospitals, ambulatory surgery centers, and health care facilities through a network of sales representatives and stocking distributors.
Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 4, 24 | -0.14 Decreased by -43.70% | -0.16 Increased by +10.19% |
| Aug 8, 24 | -0.17 Decreased by -30.77% | -0.17 |
| May 8, 24 | -0.18 Decreased by -63.64% | -0.12 Decreased by -50.00% |
| Feb 29, 24 | -0.23 Decreased by -53.33% | -0.09 Decreased by -155.56% |
| Nov 7, 23 | -0.10 Increased by +23.08% | -0.10 |
| Aug 2, 23 | -0.13 Increased by 0.00% | -0.10 Decreased by -30.00% |
| May 4, 23 | -0.11 Increased by +8.33% | -0.10 Decreased by -10.00% |
| Mar 2, 23 | -0.15 Decreased by -87.50% | -0.10 Decreased by -50.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 62.34 M Increased by +18.10% | -12.34 M Decreased by -48.08% | Decreased by -19.79% Decreased by -25.39% |
| Jun 30, 24 | 61.02 M Increased by +19.62% | -13.78 M Decreased by -26.46% | Decreased by -22.59% Decreased by -5.72% |
| Mar 31, 24 | 61.08 M Increased by +17.38% | -15.23 M Decreased by -68.29% | Decreased by -24.94% Decreased by -43.37% |
| Dec 31, 23 | 60.56 M Increased by +17.58% | -19.56 M Increased by +49.54% | Decreased by -32.30% Increased by +57.08% |
| Sep 30, 23 | 52.78 M Increased by +14.73% | -8.33 M Increased by +14.32% | Decreased by -15.79% Increased by +25.32% |
| Jun 30, 23 | 51.01 M Increased by +20.03% | -10.90 M Decreased by -13.49% | Decreased by -21.36% Increased by +5.45% |
| Mar 31, 23 | 52.04 M Increased by +25.78% | -9.05 M Increased by +1.99% | Decreased by -17.40% Increased by +22.08% |
| Dec 31, 22 | 51.51 M Increased by +20.42% | -38.76 M Decreased by -527.84% | Decreased by -75.26% Decreased by -421.38% |